Canada Markets close in 2 hrs 13 mins

Ampio Pharmaceuticals, Inc. (APH.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0459-0.0049 (-9.65%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.4700
52 Week Low 30.0459
50-Day Moving Average 30.0917
200-Day Moving Average 30.2603

Share Statistics

Avg Vol (3 month) 3230
Avg Vol (10 day) 3N/A
Shares Outstanding 5227.13M
Implied Shares Outstanding 6N/A
Float 8210.2M
% Held by Insiders 17.64%
% Held by Institutions 121.67%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Mar 31, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.40%
Return on Equity (ttm)-97.59%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.66M
Net Income Avi to Common (ttm)-19.04M
Diluted EPS (ttm)-0.0760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.4M
Total Cash Per Share (mrq)0.13
Total Debt (mrq)851k
Total Debt/Equity (mrq)3.82
Current Ratio (mrq)5.41
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-14.89M
Levered Free Cash Flow (ttm)-6.55M